---
title: Aldeyra Therapeutics vs ProSciento
slug_a: aldeyra
slug_b: prosciento
site: cro
review_signal_gate: closed
canonical_path: /compare/aldeyra/prosciento
---

# Aldeyra Therapeutics vs ProSciento

Side-by-side profile data from each company listing on this directory.

## Aldeyra Therapeutics

- Profile: [/companies/aldeyra](/companies/aldeyra)

Aldeyra Therapeutics — Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

Services: 5. Modalities: 1. Indications: 3. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations
- US FDA Regulatory Strategy
- Immunology & Inflammation Services

### Modalities

- Small Molecule

### Indications

- Immunology
- Rare Disease
- Ophthalmology

### Phases

- Phase II
- Phase III

### Sourcing models

- Data not yet provided.

## ProSciento

- Profile: [/companies/prosciento](/companies/prosciento)

ProSciento — Specialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.

Services: 5. Modalities: 0. Indications: 3. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations

### Modalities

- Data not yet provided.

### Indications

- Metabolic
- Cardiovascular
- Nephrology

### Phases

- Phase I
- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)